"Hydroxyindoleacetic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D006897
|
| MeSH Number(s) |
D03.066.288.478 D03.633.100.473.404.478
|
| Concept/Terms |
Hydroxyindoleacetic Acid- Hydroxyindoleacetic Acid
- Acid, Hydroxyindoleacetic
- 5-Hydroxyindolamine Acetic Acid
- 5 Hydroxyindolamine Acetic Acid
- Acetic Acid, 5-Hydroxyindolamine
- Acid, 5-Hydroxyindolamine Acetic
- 5-HIAA
- 5-Hydroxy-3-Indoleacetic Acid
- 5 Hydroxy 3 Indoleacetic Acid
- Acid, 5-Hydroxy-3-Indoleacetic
|
Below are MeSH descriptors whose meaning is more general than "Hydroxyindoleacetic Acid".
Below are MeSH descriptors whose meaning is more specific than "Hydroxyindoleacetic Acid".
This graph shows the total number of publications written about "Hydroxyindoleacetic Acid" by people in this website by year, and whether "Hydroxyindoleacetic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 5 | 6 |
| 1995 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hydroxyindoleacetic Acid" by people in Profiles.
-
Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome. J Clin Oncol. 2017 Jan; 35(1):14-23.
-
Telotristat etiprate for carcinoid syndrome: a single-arm, multicenter trial. J Clin Endocrinol Metab. 2015 Apr; 100(4):1511-9.
-
Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide. Endocr Relat Cancer. 2014 Oct; 21(5):705-14.
-
The saturated fatty acid, palmitic acid, induces anxiety-like behavior in mice. Metabolism. 2014 Sep; 63(9):1131-40.
-
Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX(3)CR1)-deficient mice. Brain Behav Immun. 2013 Jul; 31:134-42.
-
The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome. Gastroenterology. 2011 Aug; 141(2):507-16.
-
Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proc Natl Acad Sci U S A. 2009 Dec 22; 106(51):21966-71.
-
Indirect biochemical evidence that reserpine methiodide produces selective depletion of peripheral biogenic amines in rats. Pharmazie. 2005 Apr; 60(4):294-7.
-
Reserpine methonitrate, a novel quaternary analogue of reserpine augments urinary excretion of VMA and 5-HIAA without affecting HVA in rats. BMC Pharmacol. 2004 Nov 16; 4:30.
-
Infant rats with chronic neonatal isolation experience show decreased extracellular serotonin levels in ventral striatum at baseline and in response to cocaine. Brain Res Dev Brain Res. 2004 Aug 18; 152(1):19-24.